|Articles|February 1, 2020
- Pharmaceutical Executive-02-01-2020
- Volume 40
- Issue 2
Pharmaceutical Executive, February 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Improving the Link from Lab to Physicianover 5 years ago
Engaging the New HCP in the Digital Worldover 5 years ago
Jay Galeota: A Better Way to Pharmaover 5 years ago
Surfacing Insights: AI and the Physicianover 5 years ago
Becoming a Pharma Industry Leaderover 5 years ago
Unlocking the Black Box of Pharma Pricing in Europeover 5 years ago
The Risks and Rewards of Expedited Reviewover 5 years ago
Using Service to Drive Commercial Valueover 5 years ago
The Roots and Rise of Cell and Gene Therapyover 5 years ago
Pharma Outsourcing: Keys to Productivity in 2020sNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
4
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
5
